Optimizing Pharmacokinetics-Pharmacodynamics of Antimicrobial Management in Patients with Sepsis: A Review.

The Journal of Infectious Diseases
Kady PheV H Tam

Abstract

Critically ill patients with sepsis or septic shock are at an increased risk of death. Early and aggressive interventions are essential for improving clinical outcomes. There are a number of therapeutic and practical challenges in the management of antimicrobials in patients with sepsis. These include the timely selection and administration of appropriate antimicrobials, significant physiological alterations that can influence antimicrobial pharmacokinetics, and significant interpatient variability of antimicrobial concentrations using standard dosing approaches. Understanding the impact of these factors on the probability of attaining pharmacokinetic-pharmacodynamic target goals is essential to guide optimal therapy. Using rapid diagnostic technology could facilitate timely selection of antimicrobials, and therapeutic drug monitoring would provide a more individualized dosing approach. Using an interdisciplinary sepsis team would also be beneficial in coordinating efforts to overcome the challenges encountered during this critical period to ensure optimal care.

References

Jan 1, 1991·European Journal of Clinical Pharmacology·C TriginerF Jane
Apr 1, 1989·DICP : the Annals of Pharmacotherapy·M W PerkinsB DeHaven
Apr 12, 2003·Critical Care Medicine·Mitchell M LevyUNKNOWN SCCM/ESICM/ACCP/ATS/SIS
Sep 5, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Cheol-In KangKang-Won Choe
Sep 13, 2003·Chest·David Di GiantomassoRinaldo Bellomo
Nov 16, 2004·Critical Care Medicine·Richard J BealeJoseph E Parrillo
Mar 29, 2005·Antimicrobial Agents and Chemotherapy·Scott T MicekMarin H Kollef
Jun 9, 2005·Critical Care Medicine·Jan Willem KuiperFrans B Plötz
Sep 16, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robin L TrotmanWilliam L Salzer
Dec 5, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Paul G AmbroseGeorge L Drusano
Jan 6, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas P LodiseGeorge L Drusano
Feb 20, 2007·Antimicrobial Agents and Chemotherapy·Chonghua LiDavid P Nicolau
Apr 23, 2009·Critical Care Medicine·Jason A RobertsJeffrey Lipman
Aug 22, 2009·Chest·Anand KumarUNKNOWN Cooperative Antimicrobial Therapy of Septic Shock Database Research Group
Dec 15, 2010·Clinical Pharmacokinetics·Marta UlldemolinsJeffrey Lipman
Jul 9, 2011·The Journal of Emergency Medicine·Eveline A HittiPaul Gurny
May 4, 2012·Chest·Brian S SmithJeffrey Fong
Aug 15, 2012·Nephron. Clinical Practice·Arif Khwaja
Oct 17, 2012·Critical Care : the Official Journal of the Critical Care Forum·Kiran ShekarJohn F Fraser
Jan 24, 2013·The Annals of Pharmacotherapy·Heather M ArnoldMarin H Kollef
May 25, 2013·Journal of the American Society of Nephrology : JASN·Sheldon Chen
Oct 23, 2013·The American Journal of Emergency Medicine·Kathryn C FrankelNeil B Jasani
Jan 17, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jason A RobertsUNKNOWN DALI Study
Jan 21, 2014·The Journal of Antimicrobial Chemotherapy·Gloria WongJason A Roberts
Apr 29, 2014·The Lancet Infectious Diseases·Jason A RobertsUNKNOWN International Society of Anti-Infective Pharmacology and the Pharmacokinetics and Pharmacodynamics Study Group of the Europe
Dec 3, 2014·The American Journal of Emergency Medicine·A Brad HallTim Regan
Mar 10, 2015·International Journal of Antimicrobial Agents·Jan J De WaeleJason A Roberts
Jan 19, 2017·Critical Care Medicine·Andrew RhodesR Phillip Dellinger
Jan 20, 2017·Intensive Care Medicine·Andrew RhodesR Phillip Dellinger
Mar 23, 2017·Critical Care : the Official Journal of the Critical Care Forum·Amy L DzierbaDaniel Brodie
Mar 28, 2017·American Journal of Respiratory and Critical Care Medicine·Vincent X LiuGabriel J Escobar
May 23, 2017·The New England Journal of Medicine·Christopher W SeymourMitchell M Levy
Dec 8, 2017·The Journal of Antimicrobial Chemotherapy·Johan W MoutonJohn Turnidge

❮ Previous
Next ❯

Citations

Jul 22, 2020·The Journal of Infectious Diseases·Edward J Septimus
Nov 13, 2020·Clinical Microbiology Reviews·Dafna YahavLeonard Leibovici
Jul 3, 2021·Pharmaceutics·Alicia Rodríguez-GascónArantxa Isla
Jul 3, 2021·Microorganisms·Pedro PóvoaLuís Coelho

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Pharmacy and Therapeutics
Bita ShahramiMojtaba Mojtahedzadeh
Intensive Care Medicine
T TängdénInfection Section for the European Society of Intensive Care Medicine, the Pharmacokinetics and Pharmacodynamics Study Group
© 2021 Meta ULC. All rights reserved